Cancer Biology Faculty Candidate

  • May 18, 2021
  • 12:00 PM - 1:00 CST
  • zoom
  • Lorelei Martin,
  • No cost
  • Not open to the public.
  • Add to calendar
  • Details

    *A first-in-class Polymerase Theta inhibitor (POLQi) selectively targets Homologous Recombination-Deficient Tumors*
    Presenter: Jia Zhou, PhD
    Instructor in Radiation Oncology
    Dana-Farber Cancer Institute
    Harvard Medical School
    Interested in attending? Please contact Lorelei Martin,, for the Zoom link.